Next Article in Journal
Steady Enhancement in Photovoltaic Properties of Fluorine Functionalized Quinoxaline-Based Narrow Bandgap Polymer
Next Article in Special Issue
Efflux Inhibitor Bicalutamide Increases Oral Bioavailability of the Poorly Soluble Efflux Substrate Docetaxel in Co-Amorphous Anti-Cancer Combination Therapy
Previous Article in Journal
Immunomodulatory Effect of Vitamin D and Its Potential Role in the Prevention and Treatment of Type 1 Diabetes Mellitus—A Narrative Review
Previous Article in Special Issue
Permeability Characteristics of a New Antifungal Topical Amphotericin B Formulation with γ-Cyclodextrins
Open AccessArticle

Properties of Therapeutic Deep Eutectic Solvents of l-Arginine and Ethambutol for Tuberculosis Treatment

1
LAQV, REQUIMTE, Departamento de Química da Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, 2829-516 Caparica, Portugal
2
ITQB–Instituto de Tecnologia Química e Biológica, Universidade Nova de lisboa, Estação Agronómica Nacional, Av. Da República, 2780-157 Oeiras, Portugal
*
Author to whom correspondence should be addressed.
Academic Editors: Guy Van den Mooter, Holger Grohganz, Korbinian Löbmann and Thomas Rades
Molecules 2019, 24(1), 55; https://doi.org/10.3390/molecules24010055
Received: 12 November 2018 / Revised: 19 December 2018 / Accepted: 21 December 2018 / Published: 24 December 2018
(This article belongs to the Collection Poorly Soluble Drugs)
The treatment for tuberculosis infection usually involves a prolonged regimen of multiple antibacterial drugs, which might lead to various secondary effects. For preventing drug resistance and side-effects of anti-tuberculosis drugs, new methods for improving the bioavailability of APIs were investigated. The strategy proposed consists of the preparation of therapeutic deep eutectic solvents (THEDES), that incorporate l-arginine and ethambutol. The eutectic mixtures were prepared by mixing the components at a certain molar ratio, until a clear liquid solution was formed. The prepared mixtures were characterized by differential scanning calorimetry (DSC), polarized optical microscopy (POM) and nuclear magnetic resonance spectroscopy (1H and 13C-NMR). The solubility and permeability of the drugs when they are in the THEDES form was evaluated at 37 °C, in phosphate buffered saline (PBS). Solubility studies showed an increase of the solubility of ethambutol when incorporated in the eutectic system. The cytotoxicity was evaluated using a model cell line (Caco-2), comparing the cytotoxicity of the API incorporated in the eutectic system. We observed that the cell viability in the THEDES was affected by the presence of citric acid, and higher cytotoxicity values were observed. Nonetheless, these findings do not compromise the possibility to use these systems as new delivery systems for ethambutol and arginine. View Full-Text
Keywords: therapeutic deep eutectic solvents; tuberculosis; ethambutol; l-arginine therapeutic deep eutectic solvents; tuberculosis; ethambutol; l-arginine
Show Figures

Graphical abstract

MDPI and ACS Style

Santos, F.; P.S. Leitão, M.I.; C. Duarte, A.R. Properties of Therapeutic Deep Eutectic Solvents of l-Arginine and Ethambutol for Tuberculosis Treatment. Molecules 2019, 24, 55.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop